Related Experiment Videos
Home intravenous antibiotic treatment in cystic fibrosis
J Gilbert1, T Robinson, J M Littlewood
1Regional Cystic Fibrosis Unit, St James's University Hospital, Leeds.
Insights
Home intravenous antibiotic treatment for cystic fibrosis patients colonized with Pseudomonas aeruginosa significantly improves weight and respiratory function. Patients preferred home treatment, highlighting the benefits of this approach over traditional hospitalization.
Area of Science:
- Pulmonology
- Infectious Diseases
- Patient Care Management
Background:
- Cystic fibrosis (CF) patients colonized with Pseudomonas aeruginosa often require prolonged intravenous antibiotic treatment.
- Hospitalization for intravenous antibiotics presents challenges and limitations for CF patients.
Purpose of the Study:
- To evaluate the efficacy and patient experience of home intravenous antibiotic treatment for CF patients.
- To assess the role of a CF liaison sister in facilitating home treatment.
Main Methods:
- A prospective study over 20 months involving 13 CF patients receiving 40 courses of home intravenous antibiotic treatment.
- Inclusion of a dedicated CF liaison sister for home visit support and treatment oversight.
Main Results:
- Significant improvements observed in patient weight, respiratory function, and white blood cell count during home treatment.
- No significant difference in weight and FEV1 between home and hospital treatment endpoints; improved FVC after home treatment.
- All patients expressed a preference for home treatment over hospitalization.
Conclusions:
- Home intravenous antibiotic treatment is a viable and preferred alternative to hospitalization for CF patients.
- The involvement of a CF liaison sister is crucial for successful home-based treatment delivery.
- Home treatment offers significant clinical benefits and improved patient quality of life.
Abstract:
The prognosis for patients with cystic fibrosis who are colonised with Pseudomonas aeruginosa has improved as a result of the regular use of intravenous antibiotics; however, this necessitates long periods of hospitalisation. Home intravenous antibiotic treatment has potential advantages over hospital treatment. We describe our experience during the first 20 months of using a system of home intravenous antibiotic treatment in which a cystic fibrosis liaison sister has an essential role. Thirteen patients have received 40 courses of treatment. There were highly significant improvements in weight, respiratory function, and white cell count during home treatment. There was no significant difference in weight and forced expiratory volume in one second between the end of home treatment and the end of hospital treatment while forced vital capacity was better after home treatment. All patients preferred home treatment. The advantages of home visits by the cystic fibrosis liaison sister during treatment are emphasised.